Revenues, Expenses and Operating Income (Loss) by Market Segment |
Revenues, expenses and operating income (loss) by market segment were as follows (in thousands):
|
For the Three Months Ended |
|
|
|
For the Nine Months Ended |
|
|
September 30, |
|
|
|
September 30, |
|
|
2015 |
|
|
2014 |
|
|
|
2015 |
|
|
2014 |
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cosmetic market |
$ |
923 |
|
|
$ |
970 |
|
|
|
$ |
2,648 |
|
|
$ |
2,519 |
|
Biomedical market |
|
1,213 |
|
|
|
993 |
|
|
|
|
2,925 |
|
|
|
2,681 |
|
Total revenues |
|
2,136 |
|
|
|
1,963 |
|
|
|
|
5,573 |
|
|
|
5,200 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Therapeutic market |
|
1,180 |
|
|
|
2,458 |
|
|
|
|
4,732 |
|
|
|
7,067 |
|
Cosmetic market |
|
872 |
|
|
|
837 |
|
|
|
|
2,361 |
|
|
|
2,410 |
|
Biomedical market |
|
706 |
|
|
|
702 |
|
|
|
|
2,005 |
|
|
|
2,065 |
|
Total operating expenses |
|
2,758 |
|
|
|
3,997 |
|
|
|
|
9,098 |
|
|
|
11,542 |
|
Operating income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Therapeutic market |
|
(1,180 |
) |
|
|
(2,458 |
) |
|
|
|
(4,732 |
) |
|
|
(7,067 |
) |
Cosmetic market |
|
51 |
|
|
|
133 |
|
|
|
|
287 |
|
|
|
109 |
|
Biomedical market |
|
507 |
|
|
|
291 |
|
|
|
|
920 |
|
|
|
616 |
|
Total operating loss |
$ |
(622 |
) |
|
$ |
(2,034 |
) |
|
|
$ |
(3,525 |
) |
|
$ |
(6,342 |
) |
|
Summary of Significant Revenues in Following Regions |
Significant revenues in the following regions are those that are attributable to the individual countries within the region to which the product was shipped (in thousands):
|
For the Three Months Ended |
|
|
|
For the Nine Months Ended |
|
|
September 30, |
|
|
|
September 30, |
|
|
2015 |
|
|
2014 |
|
|
|
2015 |
|
|
2014 |
|
North America |
$ |
1,674 |
|
|
$ |
1,519 |
|
|
|
$ |
4,444 |
|
|
$ |
4,186 |
|
Asia |
|
362 |
|
|
|
332 |
|
|
|
|
844 |
|
|
|
672 |
|
Europe |
|
91 |
|
|
|
98 |
|
|
|
|
251 |
|
|
|
309 |
|
All other regions |
|
9 |
|
|
|
14 |
|
|
|
|
34 |
|
|
|
33 |
|
Total |
$ |
2,136 |
|
|
$ |
1,963 |
|
|
|
$ |
5,573 |
|
|
$ |
5,200 |
|
|